Your browser doesn't support javascript.
loading
Integrative discovery of treatments for high-risk neuroblastoma.
Almstedt, Elin; Elgendy, Ramy; Hekmati, Neda; Rosén, Emil; Wärn, Caroline; Olsen, Thale Kristin; Dyberg, Cecilia; Doroszko, Milena; Larsson, Ida; Sundström, Anders; Arsenian Henriksson, Marie; Påhlman, Sven; Bexell, Daniel; Vanlandewijck, Michael; Kogner, Per; Jörnsten, Rebecka; Krona, Cecilia; Nelander, Sven.
Afiliación
  • Almstedt E; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Elgendy R; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Hekmati N; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Rosén E; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Wärn C; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Olsen TK; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, SE-17176, Stockholm, Sweden.
  • Dyberg C; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, SE-17176, Stockholm, Sweden.
  • Doroszko M; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Larsson I; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Sundström A; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Arsenian Henriksson M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
  • Påhlman S; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, SE-223 81, Lund, Sweden.
  • Bexell D; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, SE-223 81, Lund, Sweden.
  • Vanlandewijck M; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
  • Kogner P; Department of Medicine, Integrated Cardio-Metabolic Centre Single Cell Facility, Karolinska Institutet, SE-17177, Stockholm, Sweden.
  • Jörnsten R; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, SE-17176, Stockholm, Sweden.
  • Krona C; Mathematical Sciences, Chalmers University of Technology, Gothenburg, SE-41296, Sweden.
  • Nelander S; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85, Uppsala, Sweden.
Nat Commun ; 11(1): 71, 2020 01 03.
Article en En | MEDLINE | ID: mdl-31900415
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuroblastoma / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuroblastoma / Antineoplásicos Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Suecia